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Background: Fever is common in malignant tumors. We report an exceptional case of psychogenic fever in a patient
with small cell lung cancer. This is the first case report of psychogenic fever in a patient with small cell lung cancer.
Case presentation: A 61-year-old Chinese man diagnosed with small cell carcinoma on June 30, 2012, came to our
department with a complaint of fever lasting more than 1 month. He had undergone chemoradiotherapy for lung
cancer 6 months previously. After admission, his body temperature fluctuated in the range of 37 °C to 39 °C. Somatic
symptoms associated with anxiety were obvious. A 24-item Hamilton Anxiety Scale was used to assess the patient’s
condition. A score of 32 confirmed a diagnosis of severe anxiety. After a week of antianxiety treatment, the patient’s
temperature returned to normal.
Conclusion: Psychogenic fever is common in cancer patients and deserves more attention. Patients with psychogenic
fever must be distinguished from patients with infectious fever (including neutropenic fever), and tumor fever.
Additionally, antianxiety or antidepression treatment should be provided. A concern is that continual anxiety may
adversely affect anticancer therapy.
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Psychogenic fever is higher than normal body temperature
during conditions of acute or persistent psychological
stress. Psychogenic fever has been reported in patients
3–56 years old with a sex ratio of 1:1.19 (male vs female)
[1]. Many studies have demonstrated that psychological
stress affects core body temperature in laboratory animals,
with acute stress inducing transient hyperthermia [2, 3]
and repeated, chronic stress inducing persistent low-grade
hyperthermia [4, 5], which facilitates a hyperthermic
response to novel stressors [6]. Animal studies have sug-
gested that the presence of β-endorphin, a corticotropin-
releasing hormone, and noradrenaline within the brain,
along with activation of the sympathetic nervous system,
are involved in acute stress-induced hyperthermia [7].
Habitual hyperthermia in young women, many of whom
are under treatment for neuroses, has attracted increasing
interest in recent years. In some cases anxiety or tension
seems to be responsible, and expression of the problem,
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unless otherwise stated.has resulted in defervescence [8]. Such mechanisms may
have contributed to the increase in core temperature (Tc)
in our patient. Pyrogenic cytokines induced by stress may
increase Tc in patients with psychogenic fever. However,
to date, little is known about how psychological stress
elevates Tc in patients with psychogenic fever or in other-
wise healthy subjects.
Patients with lung cancer, especially in an advanced
stage, often manifest the symptom of fever. The most
common causes for this are infection (including those
associated with neutropenic fever due to radiotherapy
and/or chemotherapy), followed by tumor fever induced
by tumor progression or high tumor burden. Cancer is
often accompanied by anxiety and depression, which
results in psychogenic fever.
Though not commonly reported, psychogenic fever is
one of the symptoms of anxiety and depression. To our
knowledge, psychogenic fever has not been reported in
patients with cancer, but we encountered what we
believe to be a case in our clinical practice that is of
interest. After receiving treatment with antianxiety
agents, both the elevated body temperature and anxiety
were significantly alleviated.is an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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The patient was a married 61-year-old male. On June 21,
2012, a computed tomography (CT) scan of the chest
showed a left lung space-occupying lesion and small cell
carcinoma that was subsequently confirmed by broncho-
scopic biopsy. His TNM classification was T2N1M0 with
clinical staging IIB. After completion of four cycles of
chemotherapy consisting of etoposide plus cisplatin, he
underwent one course of concomitant lung radiotherapy
treatment of unknown radiation dose. After chemora-
diotherapy the cancer was in complete remission as of
Octobor 2012. In November 2012, the patient developed
fever without obvious causes, with a temperature fluctu-
ation between 37.5 °C and 39.8 °C, with no chills or shiver-
ing, no cough, no sputum, no abdominal pain or sore
throat, no urinary frequency or urgency, or dysuria. The
patient successively received intravenous infusions of cefox-
itin, moxifloxacin, meropenem, fluconazole and vanco-
mycin for anti-infection treatment in another hospital, but
his temperature did not improve.
On December 19, 2012, the patient was admitted to our
department with a complaint of fever lasting for more
than 1 month. He had undergone chemoradiotherapy for
lung cancer 6 months previously. After admission, theFig. 1 Clinical course. Blue lines and X-marks shows axillary temperature; re
was measured 4 times daily: at 6:00 a.m.; 10:00 a.m.; 2:00 p.m.; and 8:00 p.m
spontaneously fell down,and he did not take any antipyretics. After anti-an
normal level (black arrow)patient experienced intermittent fever, and his body
temperature fluctuated in the range of 37 °C to 39 °C
(Fig. 1). There were no chills, shivering, cough or expec-
toration, but the patient had disordered sleep, facial
flushing, an anxious facial expression, chest discomfort,
palpitation and shortness of breath. He seemed agitated
and spoke very quickly with stuttering, and had frequent
nocturnal urination (5 times/night). The patient denied
any history of tuberculosis, hepatitis or other infectious
diseases, and had no family history of hypertension,
diabetes or tumor.
Physical examination showed: temperature 38.2 °C,
respiratory rate 22 breaths per minute, blood pressure
130/85 mm Hg, and heart rate 115 beats/min. There
was no skin redness, swelling burning sensation, or pain.
His eyelids quivered when closed. His hands shook
slightly and there was slight redness of the pharynx. His
tonsils were not enlarged. He had neither dry nor wet
rales. The heart sound was clear without murmur and
with a normal heart rhythm. There was no abdominal
tenderness or rebound pain, no percussive pain in the
liver or kidney area, and no tenderness in the gall
bladder or appendix area.
Blood and urine biochemical indices were all within a
normal range. The result of a 1-3-beta-glucan test wasd lines and circles mean changes of heart rate. Axillary temperature
. (blue line). In the process of his intermittent fever ,his temperature
xiety treatment, the axillary temperature of the patient returned to
Xu et al. BMC Cancer  (2015) 15:445 Page 3 of 4less than 10 pg/mL. Other test results were: white blood
cell count: 9.4*109/L; neutrophils 72.5 %; (twice), C-
reactive protein < 3.300 mg/L; fasting plasma glucose: 5.4
mmoL/L; hepatitis virus was negative. CT showed no
calcification segmentation. Pulmonary CT was performed
in December 20, 2012 and signs of pulmonary interstitial
fibrosis were noted in the left lower lobe and the medial
segment of the right middle lobe of the lungs (Fig. 2).
In consultation with physicians from the psychology
department in our hospital, a 24- item Hamilton Anxiety
Scale was used to assess the patient’s condition. A score
of 32 confirmed a diagnosis of severe anxiety. Of all the
items on that scale, the scores for the sub-items insom-
nia, anxious mood and depressive mood were among
the top 3 ratings (3, 4, and 4, respectively), and corre-
sponding somatic symptoms were obvious: under assess-
ment, the patient was nervous with his hands clasped,
while his facial muscles clearly twitched, showing an
obvious pallor and stiff face.
A previous combination of antibiotics had no effect. The
patient had a history of radiation therapy, so fibrotic
changes in the pulmonary interstitium were considered
radiation-induced pulmonary fibrosis. The clinical diagno-
sis was severe anxiety, psychogenic fever; right central-type
lung cancer; and radiation-induced pulmonary fibrosis.
The treatment course consisted of duloxetine (Eli Lilly
and Company) 30 mg/day, clonazepam (Nhwa Pharma.
Corp.) 0.5 mg/day; 4 days later, the duloxetine dose was
increased to 60 mg/day and the clonazepam dose was
increased to 1.0 mg/day. After 1 week, the patient’s
temperature returned to normal (Fig. 1) and his sleep
disorder resolved. He was without facial flushing and the
symptoms such as chest discomfort and shortness of
breath also improved. The palpitations and agitation re-
solved, his speech rate became normal and stuttering
stopped. The quivering in his eyelid was significantly al-
leviated and the hand trembling disappeared. Nocturnal
urinary frequency improved and his anxiety was signifi-
cantly improved. The Hamilton Anxiety Scale retest
score was 14, and the scores on the sub-items insomnia,
anxious mood and depressive mood were 1, 2 and 1,
respectively. Considering his condition, the patient wasFig. 2 CT scan results. Computed tomography scan of the chest taken pos
central type cancer of the left lung, radiation pulmonary fibrosisdiagnosed with mild anxiety and discharged. After dis-
charge, a brain metastasis was found at a local hospital
in April 2013, but he did not accept further treatment
and subsequently died in June 2013. However, the
psychogenic fever did not recur during this period.Discussion
The differential diagnosis of psychogenic fever is of great
importance. In general, infectious fever should first be
excluded. In our patient, routine blood tests performed
multiple times were within normal ranges, percussive
pain was negative in the renal region, and urinary tract
infection was excluded. The patient had received anti-
fungal (fluconazole) therapy in another hospital without
result so fungal infection was excluded. The patient had
no abdominal distension or pain, and whole abdomen
tenderness, rebound tenderness and Murphy’s sign were
all negative. Appendix area tenderness was also negative,
thus peritonitis, cholecystitis and appendicitis were ex-
cluded. No manifestations of infection such as superficial
skin redness, swelling, burning sensation or pain were
observed. The blood culture was negative. Given the lack
of evidence of infection or toxic symptoms, fever
induced by a skin infection or sepsis was excluded. CT
showed fibrotic imaging changes in the pulmonary inter-
stitium in the left lower lobe and medial segment of the
right middle lobe, which were differentiated from atyp-
ical pneumonia. Because Mycoplasma pneumoniae,
Chlamydia pneumoniae and Legionella antibodies were
all negative, and the patient had once received radiother-
apy, as indicated by obvious honeycombing in his infer-
ior lobe of left lung, atypical pneumonia was excluded
and radiation-induced pulmonary fibrosis was diagnosed.
The mainstay treatment for radiation pneumonitis is oral
steroid treatment. No steroid treatment was given during
the course of the disease. Because the antianxiety agents
improved the fever in a short time, we rejected the
possibility of fever caused by radiation pneumonitis. In
addition, the patient had once received an intravenous in-
fusion of cefoxitin, moxifloxacin, meropenem and vanco-
mycin for anti-infection treatment in another hospital, att-radiotherapy on December 21, 2012 (large arrow in a and b) showing:
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thus excluding the possibility of infectious fever.
Psychogenic fever should not be confused with febrile
episodes deliberately contrived by manic patients, which
represents a variant of Munchausen syndrome [9]. In pa-
tients with cancer, stress-induced fever should be distin-
guished from tumor fever. Tumor fever is often induced
by tumor load or rapid proliferation. Other mechanisms
include tumor necrosis, which may be associated with
the release of tumor necrosis factors and other pyrogens
from dead tissue [10]. The determination of complete
remission following chemotherapy and radiotherapy also
did not support the diagnosis of tumor fever.
Psychogenic fever is very common in patients with anx-
iety and depression. Activation of the sympathetic nervous
system is known to increase core body temperature by in-
creasing thermogenesis, including non-shivering thermo-
genesis in brown adipose tissue, and by decreasing heat
loss with peripheral vasoconstriction [7]. Because this
patient’s anxiety was obvious, a Hamilton Anxiety Scale
assessment was carried out in consultation with physicians
from the psychology department of our hospital, who
diagnosed severe anxiety. After treatment with antianxiety
agents, the patient’s temperature quickly returned to nor-
mal, which further confirmed the diagnosis of psychogenic
fever. In this case, fever onset occurred about 1 month
after chemoradiotherapy, so we do not think the fever was
associated with chemoradiotherapy. We think the cause of
psychogenic fever in this case was his fear of a malignant
tumor. Fear of the malignant tumor caused mental stress,
leading to a series of pathophysiological changes that
caused fever.
Once psychogenic fever is diagnosed, prompt treat-
ment should be provided. In this case, the patient
received the combination of duloxetine and clonazepam
for antianxiety treatment, which demonstrates a better
synergistic effect and faster function than either drug
alone.Conclusion
The high incidence of anxiety in cancer patients is often
accompanied by complex physical symptoms that are eas-
ily overlooked or confused with other conditions. Somatic
symptoms associated with anxiety have seriously affected
the quality of life of cancer patients and even patient com-
pliance with anticancer treatment. Although psychogenic
fever is not common in cancer patients, it should be con-
sidered when other causes are not apparent. Patients with
psychogenic fever must be distinguished from patients
with infectious fever (including neutropenic fever) and
tumor fever. Additionally, antianxiety or anti-depression
treatments should be provided to avoid interference with
anticancer therapies.Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images. A copy of the written consent is available for
review by the editor of this journal.
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